The Sinclair Method (TSM) for the Treatment of Alcoholism. Clinical Research Findings and Best Protocol for Success Updated 2014

Similar documents
What happens if i drink on naltrexone

Naltrexone protocol alcohol

THE NALTREXONE CHALLENGE

Can you drink on naltrexone

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Medication Assisted Treatment of Substance Use Disorders

Pharmacotherapy of Alcohol Use Disorders

OPIOID ANTAGONISTS IN THE TREATMENT OF ALCOHOL DEPENDENCE: CLINICAL EFFICACY AND PREVENTION OF RELAPSE

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

If gambling treatment was evidence based, what would it look like?

BASIC VOLUME. Elements of Drug Dependence Treatment

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

THE STATE OF MEDICINE IN ADDICTION RECOVERY

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Buprenorphine as a Treatment Option for Opioid Use Disorder

Health Systems and Addiction: Provider Issues

Treating Addiction as a Chronic Illness: Why it is Finally Possible. A. Thomas McLellan Treatment Research Institute

Long term treatment for opioid dependence Antagonist therapy

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder

Management Options for Opioid Dependence:

Biological Addictions Treatment. Psychology 470. Many Types of Approaches

Treatment Alternatives for Substance Use Disorders

Foundations of Addictions

METHADONE TO BUPRENORPHINE TRANSFERS TRANSITIONING FROM METHADONE MAINTENANCE TO BUPRENORPHINE/NALOXONE

Opioid Use Disorder Treatment Initiation in Diverse Settings

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Screening, Diagnosis, and Medication Assisted Treatment for Alcohol Use Disorders

An Internist s Guide to Unhealthy Alcohol Use. Ryan Graddy, MD JHU SOM

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Depression & Alcohol

Vivitrol/Suboxone. Comparison Study Summary

Can you drink alcohol on low dose naltrexone abigail hawk photos nude Exploration of abdominal wound cpt

Neuroscience of Addiction

Your selected document

Sustained-release preparations of naltrexone for the treatment of alcohol and opioid dependence: current status

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

Naltrexone alcoholism medication amazon

Medication for the Treatment of Addiction (MAT)

CSAM-SCAM Fundamentals. Cocaine Basics. Presentation provided by David C. Marsh MD CCSAM

Start Low, Go Slow but Treat to Target

Medications For Alcohol Use Disorder. DATE: October 10, 2017 PRESENTED BY: Alann Weissman-Ward, MD, Addiction Medicine fellow

Pharmacotherapy for Alcohol Dependence

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Dr. Renner receives honoraria from Reed Medical Education

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

TSM Protocol for Physicians

SW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی

Second of two articles

the facts about BUPRENORPHINE for Treatment of Opioid Addiction

Opioid dependence: Detoxification

PHARMACOTHERAPY: INTEGRATING NEW TOOLS INTO PRACTICE

Vivitrol Vs. Suboxone

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents

Buprenorphine and MAT 101

Alcohol Support Services

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Opiate Use Disorder and Opiate Overdose

Reducing excessive alcohol use and harm in Alaska.

Heroin, Fentanyl and Other Opioids. Steve Hanson

Medication for the Treatment of Alcohol Use Disorder. Pocket Guide

Treatment Approaches for Drug Addiction

Medical Management of Substance Use Disorders: Does research translate to clinical practice

The future of pharmacological treatment.

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone

Buprenorphine & Controlled Substance Treatment Agreement

Varenicline and Other Pharmacotherapies for Tobacco Dependence

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

Medication Assisted Treatment:

IDDT Fidelity Action Planning Guidelines

Objectives 11/2/2016. Managing Patients with Substance Abuse. Off Label Disclosure. Steven Shoptaw, PhD Professor Department of Family Medicine, UCLA

MEDICATION ASSISTED TREATMENTS (MAT) FOR SUBSTANCE USE DISORDERS

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

Naltrexone is an opioid receptor antagonist that reduces

NURSING FOLLOW-UP: NALTREXONE NALTREXONE NURSING FOLLOW-UP VISIT

6B / Boswell, Grant and Slutske Day 2 August 14, 2008

Appendix F Federation of State Medical Boards

Thaddeus Ulzen MD FRCP(C)FAPA FCGP Professor & Chair, Department of Psychiatry and Behavioral Medicine, Associate Dean for Academic Affairs

Personality disorders as predictors of treatment outcome in a sample of alcohol dependent veterans with comorbid axis I disorders

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN

Medicaid and the Opioid Crisis

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Opioids Research to Practice

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Section 15.3 Long-Term Risks of Alcohol

Opioid Use Disorders &Medication Treatment

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Child Welfare and MOMS: Building Partnerships to Improve Care

Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical

Treatment Team Approaches in Substance Abuse Treatment

Treatment of Alcoholism in the United States. Evidence-Based Treatment of Alcohol Use Disorder: A Focused Examination of Naltrexone s Role

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Depression often comorbid with alcohol dependence 1.6x higher rate of alcohol dependence in depressed subjects Depressed subjects with alcohol

Transcription:

Information for Medical & Treatment Professionals The Sinclair Method (TSM) for the Treatment of Alcoholism Clinical Research Findings and Best Protocol for Success Updated 2014 "One medication, naltrexone, has been identified as a safe and effective treatment for alcohol dependence. - World Health Organization, 1996

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Updated 2014 Table of Contents Summary Selected Quotes from Significant Research About Research Findings JAMA Study Abstract Interpretation of Clinical Results Underlined, Italics & Bold Interpreting The Trial Data Trials Involving Naltrexone and/or Nalfamine Forum Naltrexone Clinical Update

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Ver: 2014.02.LB Summary In clinical trials, where Alcohol was combined with naltrexone or nalmefene, 90 out of 91 clinical trials found significant benefits. Craving, drinking levels, relapse levels and liver damage markers were found to decrease over time. (A list of all trials and their conclusions are included at the end of this booklet). Where Alcohol was NOT combined with naltrexone or nalmefene, 36 out of 37 trials found no significant benefits. Trials proved that naltrexone only worked when it is taken either just prior to drinking alcohol or during drinking. This is due to the mechanism of the drug, which relies on pharmacological extinction. Naltrexone, available in generic form in the United States and Canada, has been approved by the FDA since 1994. It is non-addictive and will cause few, if any adverse side-affects. Naltrexone can be prescribed by a family doctor, without additional requirement for counselling or psychological therapy. The Sinclair Method (TSM) protocol is as follows: The recommended dose for patients is 50mg to be taken one (1) hour before drinking. Patients may start naltrexone while intoxicated without adverse affect. No detoxification prior to treatment is required. Naltrexone is often prescribed incorrectly (without drinking). If used this way it will be no more effective than placebo. The Sinclair Method advises against using naltrexone during periods of abstinence. When patients are directed to take naltrexone according to the TSM protocol (one hour before drinking, and not on days when no drinking occurs) chances of success are greatest: 75% success rate in Finnish clinics; 85% in Florida clinics and 75% success rate in the NGO (CORD) trial in India have been documented. The NationaI Institute on Alcohol Abuse & Alcoholism (NIAAA) and the World Health Organization (WHO) estimate that current rehabilitation methods (including AA, CBT, long-term rehabilitation programs and other common non-pharmacological treatment methods) yield success rates of around 10-15%.

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Ver: 2014.02.LB Selected Quotes from Significant Research (Full Citation for All Research is Listed at the Back of this Document) "One medication, naltrexone, has been identified as a safe and effective treatment for alcohol dependence. (World Health Organization, 1996) "Of all drugs studied for the treatment of alcohol dependence, the evidence of efficacy is strongest for naltrexone... (New England Journal of Medicine, 1999) "Significant benefits of naltrexone are still present three years after start of treatment in patients always taking medication before drinking, on craving, drinking levels, and liver damage markers. (Alcoholism: Clinical and Experimental Research, 2000) "Naltrexone significantly better than placebo: lack of relapse to heavy drinking = 90% in naltrexone group vs. 61.4% (or 11.4% reported online) with placebo. (Journal of Addictive Diseases, 2000) "Naltrexone was safe and effective, especially with a high craving and a family history of alcoholism. (American Journal of Addiction, 2001) "Naltrexone may be of benefit to women who are unable to maintain total abstinence from alcohol...among those drinking, naltrexone significantly delayed the time to the second relapse and the time to the third relapse. (Alcoholism: Clinical and Experimental Research, 2008) Naltrexone reduced drinking days and heavy drinking days, plus craving in early onset drinkers and time between drinks in patients with more alcoholic relatives. (Alcoholism: Clinical and Experimental Research, 2008) "Naltrexone has been safe and effective, with a 75% success rate, when introduced in northern India with an extinction protocol including no prior detox and instruction to take naltrexone always before drinking but only when drinking is expected. (Proceedings of the Annual Meeting of the International Society on Addiction Medicine (ISAM), 2009)

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Updated 2014 About Research Findings

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Updated 2014 About Research Findings.Continued

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Updated 2014 Interpretation of Clinical Trial Results: Trials Involving Naltrexone and/or Nalfamine SUMMARY OF RESEARCH FINDINGS: When extinction was possible, 90 out of 91 clinical trials found significant benefits from the opioid antagonist. When extinction was not possible, 36 out of 37 trials found no significant benefits from the opioid antagonist. (Source: Dr. R. Eskapa, PhD; Dr. D. Sinclair, PhD DEFINITION of EXTINCTION : Extinction, refers to Pharmacological Extinction. Pharmacological extinction works on the premise that Alcohol Dependence is a form of Pavlovian conditioning. When people drink alcohol, endorphins are released into the brain, and this reinforces the behavior of drinking alcohol. Naltrexone blocks these endorphins from binding to the brain's receptors and the alcohol drinking behavior is extinguished. When extinction is possible means: Where taking the opioid blocker, such as Naltrexone or Nalmefene, WITH alcohol was possible as part of the study. When extinction was not possible means: Taking the opioid blocker WITHOUT alcohol (example: Naltrexone AND Abstinence from Alcohol) was part of the study. KEY CONCLUSION: Where Alcohol was combined with Naltrexone or Nalmefene, 90 out of 91 clinical trials found significant benefits. Where Alcohol was NOT combined with Naltrexone or Nalmefene, 36 out of 37 trials found no significant benefits.

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Updated 2014 Key: Underlined, Italics & Bold How to Interpret The Trial Data on the Following Pages

The Sinclair Method (TSM) for Alcoholism: Using Naltrexone Correctly; Information for Medical & Treatment Professionals Updated 2014 Trials Involving Naltrexone and/or Nalfamine Trials Continued on Next Page NOTES:

Trials Involving Naltrexone and/or Nalfamine

Trials Involving Naltrexone and/or Nalfamine cont.

Source: Dr. R. Eskapa, PhD; Dr. D. Sinclair, PhD

NOTES: